Six Questions For GSK Ahead Of Crucial Investor Day
'New GSK’ Will Emerge By Mid-2022
Executive Summary
Key investors have pledged more patience in CEO Walmsley’s turnaround but they will be expecting a convincing vision of the future, more dynamic, GSK.